Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: Synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 4, 2003, Pages 709-712

  Palani, Anandan ^a   Shapiro, Sherry ^a   Clader, John W ^a   Greenlee, William J ^a   Vice, Susan ^a   McCombie, Stuart ^a   Cox, Kathleen ^a   Strizki, Julie ^a   Baroudy, Bahige M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(4 BROMOPHENYL)(ETHOXYIMINO)METHYL] 1' [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4' METHYL 1,4' BIPIPERIDINE; AMIDE; CHEMOKINE RECEPTOR CCR5; PYRIMIDINE DERIVATIVE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0037294907     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)01063-6     Document Type: Article

References (22)

1. (a) Littman D.R. Cell. 93:1998;677
2. (b) Murphy P.M. Nat. Immun. 2:2001;116
3. (c) Hunt S.W. III, LaRosa G. J. Ann. Rep. Med. Chem. 33:1998;263
4. (d) Saunders J., Tarby C.M. Drug Discov. Today. 4:1999;80.
5. Berger E.A., Murphy P.M., Farber J.M. Annu. Rev. Immunol. 17:1999;657.
6. (a) Cocchi F., DeVico A.L., Garzino-Demo A., Arya S.K., Gallo R.C., Lusso P. Science. 270:1995;1811
7. (b) Michael N.L., Moore J.P. Nature Med. 5:1999;740.
8. (a) Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapoumeroulle C., Cognaux J., Forceille C., Muyldermans G., Vehofstede C., Butonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Nature. 382:1996;722
9. (b) Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Cell. 86:1996;367.
10. Michael N.L., Chang G., Louie L.G., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W. Nature Med. 3:1997;338.
11. (a) Mastrolorenzo A., Scozzafava A., Supuran C.T. J. Enz. Inh. and Med. Chem. 17:2002;69
12. (b) Mastrolorenzo A., Scozzafava A., Supuran C.T. Expert Opin. Ther. Patents. 11:2001;1245. and references sited therein.
13. (a) Baroudy, B. AIDS - 14th International Conference (Part I), New Drugs, New Targets Symposium, Barcelona, Spain, July 7-12, 2002
14. (b) Palani A., Shapiro S., Josien H., Bara T., Clader J.W., Greenlee W.J., Cox K., Strizki J., Enders M., Baroudy B.M. J. Med. Chem. 45:2002;3143
15. (c) Strizki J.M., Xu S., Wagner N.E., Wojcik L., Liu J., Hou Y., Endres M., Palani A., Shapiro S., Clader J.W., Greenlee W.J., Tagat J.R., McCombie S., Cox K., Fawzi A.B., Chou C.C., Pugliese-Sivo C., Davies L., Moreno M.E., Ho D.D., Trkola A., Stoddart C.A., Moore J.P., Reyes G.R., Baroudy B.M. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12718.
16. A preliminary account on the synthesis of heteroaryl carboxylic acids and their derivatives has been presented: McCombie, S.; Vice, S.; Tagat, J.; Lin, S, Palani, A.; Neustadt, Baroudy, B.; Strizki, J.; Enders, M.; Cox, K.; Dan, N.; Chou, C. 224th National ACS Meeting, Orlando, FL, April 7-11, 2002; MEDI-159.
17. (a) Gosl R., Meuwsen A. Ber. 92:1959;2521
18. (b) Okamoto T., Hirobe M., Ohsawa A. Chem. Pharm. Bull. 14:1966;518.
19. Gu Y.G., Bayburt E.K. Tetrahedron Lett. 37:1996;2565.
20. (a) Rathke M.W., Cowan P.J. J. Org. Chem. 50:1985;2622
21. (b) Kress T.J. Heterocycles. 38:1994;1380.
22. Cox K.A., Dunn-Meynell K., Korfmacher W.A., Broske L., Nomeir A.A., Lin C.C., Cayen M.N., Barr W.H. Drug Discov. Today. 4:1999;232.